Cell Therapy Market - Top Companies and Manufacturers

Companies Dominating the Cell Therapy Landscape

The market for cell therapy consists of many key players who are launching various strategic initiatives to expand their market position in the industry.

Nkarta, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Novartis AG
Gilead Sciences, Inc.
Bristol-Myers Squibb Company
Johnson & Johnson Services, Inc
JCR Pharmaceuticals Co., Ltd.
JW Therapeutics
Atara Biotherapeutics
Anterogen Co., Ltd.
MEDIPOST Co., Ltd.
S. BIOMEDICS
Aurion Biotech
Cytiva
Pluri Biotech Ltd.

Browse Key Market Insights with Data Illustration:

Cell Therapy Market Size & Share, Growth Report 2036

In the News

Cytiva announced the introduction of Sefia next-generation manufacturing platform to assist pharmaceutical companies and bigger healthcare providers in speeding up the manufacture of less expensive chimeric antigen receptor T (CAR T) cell therapies and offers more automation than earlier cell therapy systems which reduces the possibility of human mistake during treatment manufacture.
Pluri Biotech Ltd. has extended its operations for cell-based products to assist other businesses with their development plans for lending its expertise, resources, and infrastructure to other companies so they can create stem cells, induced pluripotent stem cells, exosomes, and immunotherapeutics.